PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1?.

ABSTRACT: BACKGROUND:Colorectal cancer (CRC) remains the fourth most common cause of cancer-related mortality worldwide. We aimed to identify key molecules and signalling pathways mediating CRC growth and metastasis. Polypyrimidine tract-binding protein 3 (PTBP3) is a member of PTB family. A prooncogenic role for PTBP3 has also been discovered in several kinds of tumors. However, the expression and biological functions of the PTBP3 are still unknown in CRC. METHODS:We analysed the expression levels of PTBP3 using tissue microarray containing 568 CRC tissues and corresponding non-tumor adjacent tissues. The correlations between the PTBP3 expression level and clinicopathological features were evaluated using the chi-square test. The functional characterization for the role and molecular mechanism of PTBP3 in CRC was investigated through a series of in vitro and in vivo experiments. RESULTS:We showed that PTBP3 expression was increased in human CRC, and high PTBP3 expression was correlated with poor five-year overall survival and disease-free survival. Moreover, PTBP3 promoted tumor cell proliferation, migration and invasion in vitro and tumor growth and metastasis in vivo. PTBP3 enhanced HIF-1? protein expression by directly binding to the 5'UTR HIF-1? mRNA and activated translation of HIF-1?. Furthermore, HIF-1? was responsible for PTBP3-induced cell migration and invasion. CONCLUSIONS:PTBP3 appears to be a novel oncogene of CRC through binding to the IRES region of HIF-1? mRNA, which regulates HIF-1? translation. PTBP3 can serve as a promising predictive biomarker for recurrence and prognosis in patients with CRC.

SUBMITTER: Hou P 

PROVIDER: S-EPMC6622005 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature